» Authors » Marta Montori-Grau

Marta Montori-Grau

Explore the profile of Marta Montori-Grau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 147
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Montori-Grau M, Barroso E, Jurado-Aguilar J, Peyman M, Wahli W, Palomer X, et al.
Cell Mol Life Sci . 2025 Jan; 82(1):43. PMID: 39825925
Nuclear growth differentiation factor 15 (GDF15) reduces the binding of the mothers' against decapentaplegic homolog (SMAD) complex to its DNA-binding elements. However, the stimuli that control this process are unknown....
2.
Zhang M, Barroso E, Ruart M, Pena L, Peyman M, Aguilar-Recarte D, et al.
Biomed Pharmacother . 2023 Oct; 167:115623. PMID: 37783154
Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR)α and β/δ agonist that has reached a phase III clinical trial for the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD). Here,...
3.
Barroso E, Montori-Grau M, Wahli W, Palomer X, Vazquez-Carrera M
Trends Pharmacol Sci . 2023 May; 44(7):457-473. PMID: 37188578
Metformin is the most prescribed drug for the treatment of type 2 diabetes mellitus (T2DM), but its mechanism of action has not yet been completely elucidated. Classically, the liver has...
4.
Montori-Grau M, Aguilar-Recarte D, Zarei M, Pizarro-Delgado J, Palomer X, Vazquez-Carrera M
Cell Commun Signal . 2022 Apr; 20(1):53. PMID: 35428325
Background: Peroxisome proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-1α) downregulation in skeletal muscle contributes to insulin resistance and type 2 diabetes mellitus. Here, we examined the effects of endoplasmic reticulum...
5.
Palomer X, Barroso E, Pizarro-Delgado J, Pena L, Botteri G, Zarei M, et al.
Int J Mol Sci . 2018 Mar; 19(3). PMID: 29558390
Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the...
6.
Montori-Grau M, Pedreira-Casahuga R, Boyer-Diaz Z, Lassot I, Garcia-Martinez C, Orozco A, et al.
Metabolism . 2018 Feb; 83:177-187. PMID: 29466708
Background: Glycogenin-interacting protein 1 (GNIP1) is a tripartite motif (TRIM) protein with E3 ubiquitin ligase activity that interacts with glycogenin. These data suggest that GNIP1 could play a major role...
7.
Ceperuelo-Mallafre V, Ejarque M, Serena C, Duran X, Montori-Grau M, Rodriguez M, et al.
Mol Metab . 2016 Feb; 5(1):5-18. PMID: 26844203
Objective: Glycogen metabolism has emerged as a mediator in the control of energy homeostasis and studies in murine models reveal that adipose tissue might contain glycogen stores. Here we investigated...
8.
Montori-Grau M, Tarrats N, Osorio-Conles O, Orozco A, Serrano-Marco L, Vazquez-Carrera M, et al.
Cell Signal . 2013 Mar; 25(5):1318-27. PMID: 23453973
Glycogen synthase (GS) is activated by glucose/glycogen depletion in skeletal muscle cells, but the contributing signaling pathways, including the chief GS regulator GSK3, have not been fully defined. The MEK/ERK...
9.
Montori-Grau M, Guitart M, Garcia-Martinez C, Orozco A, Gomez-Foix A
BMC Biochem . 2011 Nov; 12:57. PMID: 22054094
Background: PPP1R6 is a protein phosphatase 1 glycogen-targeting subunit (PP1-GTS) abundant in skeletal muscle with an undefined metabolic control role. Here PPP1R6 effects on myotube glycogen metabolism, particle size and...
10.
Montori-Grau M, Minor R, Lerin C, Allard J, Garcia-Martinez C, de Cabo R, et al.
Exp Gerontol . 2009 Apr; 44(6-7):426-33. PMID: 19341787
Calorie restriction's (CR) effects on age-associated changes in glycogen-metabolizing enzymes were studied in rat soleus (SOL) and tibialis anterior (TA) muscles. Old (24 months) compared to young (6 months) rats...